Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04956874 · ClinicalTrials.gov registry record · NA
FL-REACH: Pilot Trial of a Brief Dementia Caregiver Intervention
A NA study, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT04956874: Completed NA study, sponsored by University of Central Florida.
NCT04956874 is a NA study that has completed, run by University of Central Florida. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04956874, a NA study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The primary aim of this study is to test feasibility of a modified REACH II intervention in an outpatient clinic.
Primary Outcome
Zarit Burden Inventory
Interventions
- BEHAVIORAL FL-REACH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-10-04 |
| Est. Completion | 2020-09-17 |
| Phase | NA |
What the finished NCT04956874 record still lists
NCT04956874 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which FL-REACH is the first listed.
NCT04956874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04956874 about?
NCT04956874 is a clinical study titled "FL-REACH: Pilot Trial of a Brief Dementia Caregiver Intervention". The primary aim of this study is to test feasibility of a modified REACH II intervention in an outpatient clinic.
What is the current status of trial NCT04956874?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2019-10-04. Estimated completion is 2020-09-17.
What interventions are being tested in trial NCT04956874?
The interventions under investigation include: FL-REACH (BEHAVIORAL).
Who is sponsoring clinical trial NCT04956874?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04956874's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI